{"id":"W4411135651","doi":"10.1016/j.esmoop.2025.105125","title":"Pan-Asia adapted ESMO Clinical Practice Guideline for the management of patients with newly diagnosed and relapsed epithelial ovarian cancer","year":2025,"lang":"en","type":"article","venue":"ESMO Open","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Foundation Medicine; Bayer Yakuhin; MSD K.K.; Chugai Pharmaceutical; Pfizer Japan; EMD Serono; AstraZeneca; Genentech; Council of Scientific and Industrial Research, India; Sierra Oncology; Sanofi K.K.; INCLIVA Instituto de Investigación Sanitaria; Exelixis; International Atomic Energy Agency; PharmaMar; Daiichi Sankyo Europe; Takeda Oncology; European Society for Medical Oncology; Novocure; Seoul National University; Indian Council of Medical Research; Intas Pharmaceuticals; Seagen; European SocieTy for Radiotherapy and Oncology; Glenmark Pharmaceuticals; The Wellcome Trust DBT India Alliance; Seoul National University Hospital; MacroGenics; Sociedad Española de Oncología Médica; BeiGene; Actuate Therapeutics; Ribon Therapeutics; Sysmex Corporation; Mersana Therapeutics; Amgen; Astellas Pharma; Deciphera Pharmaceuticals; Clovis Oncology; Natera; Regeneron Pharmaceuticals; Boehringer Ingelheim Japan; Gilead Sciences; Taiho Pharmaceutical; EQRx; F. Hoffmann-La Roche; Servier; Eisai; FibroGen; Ono Pharmaceutical; Eli Lilly and Company; Bristol-Myers Squibb; American Society of Clinical Oncology; Hellenic Society of Medical Oncology; Sanofi; Pfizer; Celgene","keywords":"Guideline; Reimbursement; Medicine; Family medicine; China; Political science; Health care; Pathology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007028862,0.0001806599,0.0004459712,0.00004156962,0.0001304726,0.00005096214,0.0002377368,0.00007899224,0.0001368602],"category_scores_gemma":[0.0001733598,0.000106707,0.000077276,0.0002085364,0.00008746005,0.0001316606,0.0002023685,0.0001314885,0.000002918414],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008245608,"about_ca_system_score_gemma":0.0002433539,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004005764,"about_ca_topic_score_gemma":0.0006142107,"domain_scores_codex":[0.9984342,0.00007568696,0.0006342866,0.0004165702,0.0002377816,0.0002014875],"domain_scores_gemma":[0.9980419,0.0007255762,0.0002873395,0.0005291925,0.0003343016,0.00008174606],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.01393366,0.003536406,0.285173,0.0002496154,0.007781389,0.000102982,0.0002598075,0.00005220605,9.993838e-7,0.01404461,0.09967142,0.5751939],"study_design_scores_gemma":[0.0207923,0.0006604188,0.5936188,0.0003885194,0.002038368,7.460461e-7,0.0002012879,0.0001039793,0.00004214995,0.00008373644,0.3819813,0.00008842259],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.2432695,0.005956246,0.02466071,0.5608647,0.005853581,0.06452526,0.001766187,0.0002206884,0.09288312],"genre_scores_gemma":[0.8808282,0.003490055,0.09897867,0.0109823,0.0002398902,0.002482639,0.0002163023,0.00006078937,0.002721124],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.6375588,"threshold_uncertainty_score":0.6055543,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03089511936107969,"score_gpt":0.3789578666959741,"score_spread":0.3480627473348945,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}